Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life.

[1]  W. Blackwelder,et al.  A placebo-controlled trial of a pertussis-toxoid vaccine. , 1995, The New England journal of medicine.

[2]  M. Pichichero,et al.  Comparison of 13 acellular pertussis vaccines: overview and serologic response. , 1995, Pediatrics.

[3]  S. Halperin,et al.  Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age. , 1995, The Pediatric infectious disease journal.

[4]  C. Marwick.  Acellular pertussis vaccine hailed for infants. , 1995, JAMA.

[5]  S. Halperin,et al.  Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities. , 1994, Archives of pediatrics & adolescent medicine.

[6]  A. Podda,et al.  Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. , 1994, The Journal of pediatrics.

[7]  S. Halperin,et al.  Immunogenicity of a five-component acellular pertussis vaccine in infants and young children. , 1994, Archives of pediatrics & adolescent medicine.

[8]  E. Rothstein,et al.  Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants. , 1994, Pediatrics.

[9]  C. Svanborg,et al.  A prospective cohort study on breast-feeding and otitis media in Swedish infants. , 1994, The Pediatric infectious disease journal.

[10]  M. Pichichero,et al.  Comparison of a three-component acellular pertussis vaccine with whole cell pertussis vaccine in two-month-old children. , 1994, The Pediatric infectious disease journal.

[11]  M. Pichichero,et al.  Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study. , 1994, Pediatrics.

[12]  K. Edwards,et al.  Acellular pertussis vaccines--a solution to the pertussis problem? , 1993, The Journal of infectious diseases.

[13]  M. Pichichero,et al.  Safety and immunogenicity of an acellular pertussis vaccine booster in 15- to 20-month-old children previously immunized with acellular or whole-cell pertussis vaccine as infants. , 1993, Pediatrics.

[14]  M. Pichichero,et al.  Comparison of 13 acellular pertussis vaccines: adverse reactions. , 1993, Pediatrics.

[15]  A. Frank,et al.  Comparison of the safety and immunogenicity of acellular (BIKEN) and whole-cell pertussis vaccines in 15- to 20-month-old children. , 1993, American journal of diseases of children.

[16]  M. Pichichero,et al.  Comparison of a diphtheria and tetanus toxoids and bicomponent acellular pertussis vaccine with diphtheria and tetanus toxoids and whole-cell pertussis vaccine in infants. , 1993, American journal of diseases of children.

[17]  D. Bernstein,et al.  Comparison of acellular pertussis vaccine with whole cell vaccine as a booster in children 15 to 18 months and 4 to 6 years of age. , 1993, The Pediatric infectious disease journal.

[18]  W. P. Glezen,et al.  Controlled study of a new five-component acellular pertussis vaccine in adults and young children. , 1992, The Journal of infectious diseases.

[19]  M. Andrew,et al.  Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15- to 24-month-old children. , 1992, The Journal of pediatrics.

[20]  K. Edwards,et al.  Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. , 1992, The Journal of pediatrics.

[21]  K. Reisinger,et al.  Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17- to 24-month-old children. , 1992, The Pediatric infectious disease journal.

[22]  C. Broome,et al.  Acellular Pertussis Vaccines: Recommendations for Use as the Fourth and Fifth Doses , 1992, Pediatrics.

[23]  M. Pichichero,et al.  Acellular pertussis vaccination of 2-month-old infants in the United States. , 1992, Pediatrics.

[24]  G. Siber,et al.  Safety and immunogenicity of hydrogen peroxide-inactivated pertussis toxoid in 18-month-old children. , 1991, Vaccine.

[25]  S. Plotkin,et al.  Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants , 1991 .

[26]  K. Edwards,et al.  Booster response to acellular pertussis vaccine in children primed with acellular or whole cell vaccines , 1991, The Pediatric infectious disease journal.

[27]  C. Dekker,et al.  Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children. , 1990, American journal of diseases of children.

[28]  J. Mezzatesta,et al.  Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody. , 1990, The Journal of pediatrics.

[29]  W. Dupont,et al.  Evaluation of a new highly purified pertussis vaccine in infants and children. , 1989, The Journal of infectious diseases.

[30]  M. Granström,et al.  Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants. , 1989, Pediatrics.

[31]  H. Iwai,et al.  Efficacy and immunogenicity of acellular pertussis vaccine by manufacturer and patient age. , 1989, American journal of diseases of children.

[32]  Adhocgroupforthestudyofpert.  PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN?PROTECIVE EFFICACY AND ADVERSE EVENTS , 1988 .

[33]  R. Belshe,et al.  Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants. , 1988, The Journal of infectious diseases.

[34]  M. Pichichero,et al.  Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children. , 1987, The Pediatric infectious disease journal.

[35]  P. Varughese.  Incidence of pertussis in Canada. , 1985, Canadian Medical Association journal.

[36]  J. Cherry,et al.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. , 1981, Pediatrics.

[37]  G. Guarini,et al.  STEATORRHŒA IN ADDISON'S DISEASE , 1963 .

[38]  H. Fineberg,et al.  Adverse Effects of Pertussis and Rubella Vaccines , 1991 .

[39]  H. Fineberg,et al.  Adverse Effects of Pertussis and Rubella Vaccines: A Report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines , 1991 .

[40]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[41]  M. Granström,et al.  The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. , 1985, Journal of biological standardization.